Heart Test Laboratories Inc.
HSCS
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.05M
Close$
$-2.03
154.5% downside
Current Fair Value
154.5% downsideOvervalued by 154.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.05 Million |
|---|---|
| Enterprise Value | $-1,644,822,418.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.48 |
| Beta | 1.86 |
| Outstanding Shares | 3,162,257 |
Return
| Return on Equity | -911.89% |
|---|---|
| Return on Assets | -39170.67% |
| Return on Invested Capital | -468181.09% |
Valuation & Multiples
| P/E Ratio | -0.95 |
|---|---|
| PEG | 0.95 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -862.62 |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$50,000
Average shareholder expectationNext Earnings Call
Expected Date
September 10, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data